Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
Hunt
B J
BJ
Segal
H C
HC
Yacoub
M
M
D007611:Aprotinin / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D002315:Cardiopulmonary Bypass; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D014914:Whole Blood Coagulation Time
D006493:Heparin; D007611:Aprotinin